XDx Hopes 510(k) For Heart Transplant Rejection Test Will Aid Reimbursement
This article was originally published in The Gray Sheet
Executive Summary
Molecular diagnostics firm XDx expects 510(k) clearance for its AlloMap HTx heart transplant rejection test, previously available as a laboratory home-brew, will lead to better reimbursement and market adoption